| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.01 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.35 | 0.01 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |